Psoralen photochemotherapy (Q39679832)

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

DNA synthesis in normal and xeroderma pigmentosum fibroblasts following treatment with 8-methoxypsoralen and long wave ultraviolet light

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Abnormal cell proliferation in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Combined 8-methoxypsoralen and black light therapy of psoriasis TECHNIQUE AND RESULTS

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Psoralen Photochemotherapy of Cutaneous Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Minimal phototoxic doses and 8-MOP plasma levels in PUVA patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Difference in bioavailability between two brands of 8-methoxypsoralen and its impact on the clinical response in psoriatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Clinical pharmacokinetics of methoxsalen and other psoralens

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photochemotherapy in psoriasis-clinical response and 8-MOP plasma concentrations at two dose levels

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

The metabolism of 8-methoxypsoralen in man

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photochemotherapy (PUVA) of psoriasis using 3-carbethoxypsoralen, a non-carcinogenic compound in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Biologic effectiveness of black light fluorescent lamps for PUVA.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Production of active oxygen species (1O2 and O2⨪) by psoralens and ultraviolet radiation (320–400 nm)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Psoralen plus near ultraviolet light inactivation of cultured chinese hamster cells and its relation to DNA cross-links

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photoinactivation of Skin Fibroblasts by Fractionated Treatment with 8-Methoxypsoralen and UVA

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Immunologic implications of PUVA therapy in psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Alteration of lymphocyte functions by 8-methoxypsoralen and longwave ultraviolet radiation. I. Suppressive effects of PUVA on T-lymphocyte migration in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Spectral power distributions of radiation sources used in phototherapy and photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Current status of oral PUVA therapy for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Clinical and laboratory evaluation of 8-methoxypsoralen toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Phototesting and dosimetry for photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Clinical aspects of photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Risks and Benefits of the Treatment of Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Oral methoxsalen photochemotherapy of psoriasis and mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Oral 8-methoxypsoralen photochemotherapy of psoriasis. The European PUVA study: a cooperative study among 18 European centres

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Long-term continuation of psoralen and ultraviolet-A treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photochemotherapy for pustular psoriasis (von Zumbusch).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Long-term use of psoralens and ultraviolet A for psoriasis: evidence for efficacy and cost savings

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photochemotherapy and psoriatic arthritis. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Evaluation of PUVA, topical corticosteroids and the combination of both in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Combination therapy for psoriasis. Psoralens plus long-wave ultraviolet radiation with betamethasone valerate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Psoriasis treated with clobetasol propionate and photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photochemotherapy for psoriasis remission times. Psoralens and UV-A and combined photochemotherapy with anthralin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Combined methotrexate-PUVA therapy in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Augmentation of Oral Methoxsalen-Photochemotherapy with an Oral Retinoic Acid Derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Combined therapy with oral retinoid and PUVA baths in severe psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Therapy of psoriasis with retinoid plus PUVA: Clinical and histologic data

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Retinoids and PUVA in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

A clinical evaluation of the effects of an aromatic retinoid (Tigason), combination of retinoid and PUVA, and PUVA alone in severe psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Treatment of psoriasis by oral PUVA therapy combined with aromatic retinoid (Ro 10-9359; Tigason)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

A randomized double-blind comparison of PUVA-etretinate and PUVA-placebo in the treatment of chronic plaque psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Addition of retinoids to PUVA for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Isotretinoin-PUVA for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Trimethylpsoralen bath plus ultraviolet A combined with oral retinoid (etretinate) in the treatment of severe psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Combination of psoralens and ultraviolet A and ultraviolet B in the treatment of psoriasis vulgaris: a bilateral comparison study.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Psoralens and UV-A and UV-B twice weekly for the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Comparison of phototherapy (UV-B) and photochemotherapy (PUVA) for clearing and maintenance therapy of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Risk of carcinogenicity in patients with psoriasis treated with methotrexate or PUVA singly or in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Synergistic carcinogenic potential of methotrexate and PUVA in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Methotrexate used for psoriasis and the risk of noncutaneous or cutaneous malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Methotrexate induced liver cirrhosis. Studies including serial liver biopsies during continued treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Retinoids, a new class of compounds with prophylactic and therapeutic activities in oncology and dermatology

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Oral methoxsalen photochemotherapy of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photochemotherapy in the treatment of psoriasis and mycosis fungoides *

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photochemotherapy for mycosis fungoides: a clinical and histological study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photochemotherapy in mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

The treatment of mycosis fungoides with PUVA

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photochemotherapy for cutaneous T cell lymphoma. A follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

PUVA treatment of erythrodermic and plaque type mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Mycosis fungoides in the tumor stage treated by PUVA: a successful trial in a 12-year-old girl

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photochemotherapy of cutaneous lymphoma: oral and local 8-MOP-UVA treatment (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Treatment of parapsoriasis and mycosis fungoides: the role of psoralen and long-wave ultraviolet light A (PUVA)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Histological changes observed in the skin of patients with mycosis fungoides receiving photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Combination topical nitrogen mustard and photochemotherapy for mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Treatment of vitiligo with oral 4,5',8-trimethylpsoralen (Trisoralen)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Melanocyte changes following PUVA therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Determination of optimal topical photochemotherapy for vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

PUVA-therapy for alopecia areata. An investigative study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

An evaluation of PUVA-therapy for alopecia areata

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Topical photochemotherapy for alopecia areata

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

PUVA treatment of alopecia areata

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

PUVA treatment for alopecia areata

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Treatment of alopecia areata

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Oral psoralen photochemotherapy of atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Cell-Mediated Immunity in Untreated and PUVA Treated Atopic Dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

A controlled trial of photochemotherapy for persistent palmoplantar pustulosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Oral methoxsalen photochemotherapy of recalcitrant dermatoses of the palms and soles

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Suppression of palmoplantar pustulosis symptoms with oral 8-methoxypsoralen and high-intensity UVA irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Treatment of palmoplantar psoriasis with topical methoxsalen plus long-wave ultraviolet light

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

The effect of etretinate compared with different regimens of PUVA in the treatment of persistent palmoplantar pustulosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Phototherapy of urticaria pigmentosa: clinical response and changes of cutaneous reactivity, histamine and chemotactic leukotrienes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Trioxsalen baths plus UV-A in the treatment of lichen planus and urticaria pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

PUVA-treatment of urticaria pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Treatment of polymorphous light eruption

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Induction of UV light tolerance by PUVA in patients with polymorphous light eruption

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Comparison of PUVA and beta-carotene in the treatment of polymorphous light eruption

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Successful therapy of ichthyosis linearis circumflexa with PUVA

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

PUVA-treatment for solar urticaria and persistent light reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Solar urticaria: treatment with PUVA and mediator inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Ultraviolet A phototherapy in the prophylaxis of solar urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

PUVA treatment of scleromyxoedema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Bilateral comparison of generalized lichen planus treated with psoralens and ultraviolet A

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Psoralens and ultraviolet A therapy of pityriasis lichenoides.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Keratosis lichenoides chronica

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

PUVA-treatment in lymphomatoid papulosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Treatment of hypopigmented sarcoidosis with 8-methoxypsoralen and long wave ultraviolet light

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Response of transient acantholytic dermatosis to photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photosensitization of the eye with methoxsalen. II. Chronic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Smoldering multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Potential ocular complications from PUVA therapy and their prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

8-Methoxypsoralen and the eye

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

A retrospective study of ocular findings in patients treated with PUVA

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Dermatological and Ocular Examinations in Rabbits Chronically Photosensitized with Methoxsalen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Cataracts in a patient with vitiligo who received photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Current status of oral PUVA therapy for psoriasis. Eye protection revisions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Environmental UVA radiation and eye protection during PUVA therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

The effects of PUVA on the eye

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Toxic hepatitis from oral methoxsalen photochemotherapy (PUVA).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Preleukaemia (haemopoietic dysplasia) developing in a patient with psoriasis treated with 8-methoxypsoralen and ultraviolet light (PUVA treatment).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Mutagenicity and carcinogenicity of methoxsalen plus UV-A.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Cell killing and mutagenesis by 8-methoxypsoralen in mammalian (rodent) cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

The effect of photochemotherapy on the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

The cardiovascular stress of photochemotherapy (PUVA)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Effect of photochemotherapy on the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Nephrotic syndrome after treatment with psoralens and ultraviolet A

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Acute gout secondary to psoriasis exacerbated by photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Response of psoriatic nails to oral photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photo-onycholysis induced by 8-methoxypsoralen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Onycholysis occurring during PUVA therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photo-onycholysis Secondary to Psoralen Use

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photo-onycholysis caused by photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photo-Onycholysis Secondary to Psoralen Use

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

8-methoxypsoralen-induced nail pigmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Nail pigmentation due to oral 8-methoxypsoralen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Histological features of PUVA-induced bullae in psoriatic skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

PUVA-induced bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Bullous pemphigoid induced by PUVA therapy. Is this the aetiology of the acral bullae produced during PUVA treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Bullous pemphigoid and psoriasis: does subclinical bullous pemphigoid exist?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Hypertrichosis in PUVA-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Acne induced by PUVA treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Disseminated superficial actinic porokeratosis: appearance associated with photochemotherapy for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Excruciating skin pain after PUVA treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

The occurrence of vitiligo after psoralens and ultraviolet a therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Histologic, immunofluorescent, and antinuclear antibody findings in PUVA-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Long-term photochemotherapy: histopathological and immunofluorescence observations in 243 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Development of photosensitivity and an SLE-like syndrome in a patient with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Antinuclear antibodies and PUVA photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Histological changes produced in skin by equally erythemogenic doses of UV-A, UV-B, UV-C and UV-A with psoralens

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Epidermal dystrophy. Occurrence after psoriasis therapy with psoralen and long-wave ultraviolet light

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Epidermal dystrophy and actinic keratoses in psoriasis patients following oral psoralen photochemotherapy (PUVA). Follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Long-term and short-term histopathologic changes in the skin after PUVA therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Elastic tissue changes in skin following PUVA therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Colloid-amyloid Bodies in PUVA-treated Human Psoriatic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Amyloid deposition after psoriasis therapy with psoralen and long-wave ultraviolet light

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

The effects of long-term local PUVA treatment on collagen metabolism in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

In vivo effects of PUVA on lymphocytes function

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Photochemotherapy of psoriasis: DNA damage in blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Effects of in vitro PUVA on human leukocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Effects of PUVA on human blood monocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

T Lymphocyte E Rosette Function During Photochemotherapy (PUVA) of Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Abnormal lymphocyte function following long-term PUVA therapy for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Immunological aspects of psoriasis. IV. Presence of circulating immune complexes in patients before and after PUVA therapy; correlations with T-cell markers

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Reduction of the fraction of circulating helper-inducer T cells identified by monoclonal antibodies in psoriatic patients treated with long-term psoralen/ultraviolet-A radiation (PUVA)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Transient impairment of peripheral blood lymphocyte function during PUVA therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

UVA-induced inhibition of proliferation of PHA-stimulated lymphocytes from humans treated with 8-methoxypsoraien

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Decreased thymidine incorporation in circulating leukocytes after treatment of psoriasis with psoralen and long-wave ultraviolet light

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Influence of PUVA and UVB Radiation on Delayed Hypersensitivity in the Guinea Pig

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Systemic suppression of contact hypersensitivity in mice by psoralen plus UVA radiation (PUVA)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Effect of a single UVB or PUVA exposure on immediate and delayed skin hypersensitivity reactions in humans. Correlation to erythemal response and Langerhans cell depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

PUVA treatment in chromium hypersensitivity: Effect on skin reactivity and lymphocyte functions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

PUVA-induced diminution of contact allergic and irritant skin reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

PUVA-induced suppression of contact sensitivity to mustine hydrochloride in mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

The mechanisms of inhibitory effect of 8-methoxypsoralen and long-wave ultraviolet light on experimental contact sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Inhibition of delayed hypersensitivity reaction in skin (DNCB test) by 8-methoxypsoralen photochemotherapy. Possible basis for pseudo-promoting action in skin carcinogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

How does PUVA inhibit delayed cutaneous hypersensitivity?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Acute myelomonocytic leukaemia developing in a patient with psoriasis treated with oral 8-methoxypsoralen and longwave ultraviolet light

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Penetration of epidermis by ultraviolet rays

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Reduction of Langerhans cells in human epidermis during PUVA therapy: a morphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Giant langerhans cells induced by psoralen and ultraviolet radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Reappearance of epidermal Langerhans cells after PUVA therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Disappearance of epidermal Langerhans cells during PUVA therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

The effect of 8-methoxypsoralen and long-wave ultraviolet light on Langerhans cell

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

The human leukocyte test system. VI. The use of sister chromatid exchanges as possible indicators for mutagenic activities

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Sister chromatid exchanges, indices of human chromosome damage and repair: detection by fluorescence and induction by mitomycin C.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Sister chromatid exchanges in photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

8-methoxypsoralen and UVA promote sister-chromatid exchanges

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Acute effect of 8-methoxypsoralen and ultraviolet light on sister chromatid exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Sister chromatid exchange and chromosome aberration rates in a group of psoriatics before and after a course of PUVA treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Studies of DNA and chromosome damage in skin fibroblasts and blood lymphocytes from psoriasis patients treated with 8-methoxypsoralen and UVA irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

PUVA-induced melanocytic atypia: is it confined to PUVA lentigines?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Persistent ashen-gray maculae and freckles induced by long-term PUVA treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Psoralens and UV-A-induced stellate hyperpigmented freckling

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

The PUVA-induced pigmented macule: a lentiginous proliferation of large, sometimes cytologically atypical, melanocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

The PUVA lentigo: an analysis of predisposing factors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Morphologic alterations of epidermal melanocytes and melanosomes in PUVA lentigines: a comparative ultrastructural investigation of lentigines induced by PUVA and sunlight

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Psoralen-UVA-treated psoriatic lesions. Ultrastructural changes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Redistribution of melanosomal complexes within keratinocytes following UV-A irradiation: A possible mechanism for cutaneous darkening in man

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Comparison of Eumelanogenesis and Pheomelanogenesis in Retinal and Follicular Melanocytes; Role of Vesculo-globular Bodies in Melanosome Differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Melanosomal pattern in phototoxic pigmentary responses induced by topical psoralens and other photosensitizers

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Malignant melanoma in situ in two patients treated with psoralens and ultraviolet A

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Melanoma and psoralens and ultraviolet A

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Malignant melanoma in a patient with severe psoriasis treated by oral methoxsalen photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Case report: malignant melanoma arising during drug therapy for vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Nodular malignant melanoma and multiple squamous cell carcinomas in a patient treated by photochemotherapy for psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Psoralens, UVA (PUVA) and photocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

8-methoxypsoralen induced alterations of mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Letter: Chromosome damage produced by psoralen and ultraviolet light

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

The risk of photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Bowenoid lesions, Bowen's disease and keratoacanthomas in long-term PUVA-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Multiple keratoacanthomas possibly induced by psoralens and ultraviolet A photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Keratoses and nonmelanoma skin tumors in long-term photochemotherapy (PUVA)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Psoriasis and the risk of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Cancer in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Risk of Cutaneous Carcinoma in Patients Treated with Oral Methoxsalen Photochemotherapy for Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Psoriasis, skin cancer, and PUVA

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Skin cancer after PUVA treatment for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Skin cancer in the PUVA-48 cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Cutaneous carcinoma in psoriatic patients treated with PUVA.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Cutaneous squamous-cell carcinoma in patients treated with PUVA.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Failure of UVR dose reciprocity for skin tumorigenesis in hairless mice treated with 8-methoxypsoralen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

PUVA TREATMENT STRATEGIES AND CANCER RISK

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021

Combination therapy for psoriasis with methotrexate and etretinate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970255-2

7 January 2021